A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Soft Tissue Sarcoma

A study of lifileucel (tumor-infiltrating lymphocytes) in adults with advanced soft tissue sarcoma ('SARATOGA')

Trial Details

NCT ID
NCT07741877
Phase
PHASE2
Sponsor
Iovance Biotherapeutics, Inc.
Status
RECRUITING
Cancer Type
Sarcoma
Interventions
  • Lifileucel
Locations (sample)
  • Tampa, Florida, United States|27.94752,-82.45843
  • New York, New York, United States|40.71427,-74.00597

Key Eligibility Criteria

  • Participant must be ≥ 16 years of age at the time of signing the informed consent and assent.
  • Participants who are \> 70 years of age may be allowed to enroll after the investigator discusses with the medical monitor.
  • Participant must have a confirmed diagnosis of histologically confirmed unresectable or metastatic UPS (Cohort 1) or DDLPS (Cohort 2), with or with…
  • Participant has demonstrated progressive disease on or after the last line of therapy.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Sarcoma Trials on Trialify →